Jan 5 2023 by CNN.com - Top Stories
The death of a participant in a clinical trial of an antibody treatment for Alzheimer's disease, which is now under consideration by the US Food and Drug Administration, may be linked to the experimental drug, a new report shows.
Continue Reading Report shares new details about death possibly linked to experimental Alzheimer's drug
Request a feature